| LA | |
|---|---|
| Post | - |
| Pre | - |
| M1 | M2 | M3 | M4 | M5 | M6 | M7 | M8 | M9 | M10 | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | - | - | - | - | 7.0 | 3053.0 | 934.0 | 8.0 | - | - | 4002 |
| 1 | - | - | - | - | - | 3.0 | 3.0 | - | - | - | 6 |
| LO1 | LO2 | LO3 | LO4 | LO5a | LO5b | LO6 | Total | |
|---|---|---|---|---|---|---|---|---|
| Post | - | - | - | - | - | - | - | - |
| Pre | - | - | - | - | - | - | - | - |
| AME | |
|---|---|
| 0 | 25 |
| 1 | 1 |
| LOP1 | LOP2 | LOP3 | LOP4 | Total | |
|---|---|---|---|---|---|
| Post | - | - | - | - | - |
| Pre | - | - | - | - | - |
| central brain | |
|---|---|
| 0 | 48 |
| 1 | 102 |
| Number of post synapses: | 4002 |
| Number of pre synapses: | 6 |
| Number of output connections: | 12 |
| Coverage factor: | 1.0 |
| Columnar completeness: | 0.64 |
| Area completeness: | 0.84 |
| Cell size (columns): | 572 |
| Number of post synapses: | 0 |
| Number of pre synapses: | 0 |
| Number of output connections: | 0 |
| Coverage factor: | 0 |
| Columnar completeness: | 0 |
| Area completeness: | 0 |
| Cell size (columns): | 0 |
| Number of post synapses: | 0 |
| Number of pre synapses: | 0 |
| Number of output connections: | 0 |
| Coverage factor: | 0 |
| Columnar completeness: | 0 |
| Area completeness: | 0 |
| Cell size (columns): | 0 |
| instance | NT | total connections | connections /#MeVPMe11 (R) | % | % cumu. | |
|---|---|---|---|---|---|---|
| 0 | Mi15 (R) | ACh | 2,407 | 2,407.0 | 60.1% | 60.1% |
| 1 | MeVC20 (R) | Glu | 252 | 252.0 | 6.3% | 66.4% |
| 2 | MeTu3b (R) | ACh | 190 | 190.0 | 4.7% | 71.1% |
| 3 | Mi10 (R) | ACh | 140 | 140.0 | 3.5% | 74.6% |
| 4 | MeTu3c (R) | ACh | 131 | 131.0 | 3.3% | 77.9% |
| 5 | MeTu3a (R) | ACh | 119 | 119.0 | 3.0% | 80.9% |
| 6 | Cm20 (R) | GABA | 99 | 99.0 | 2.5% | 83.3% |
| 7 | Cm12 (R) | GABA | 81 | 81.0 | 2.0% | 85.3% |
| 8 | Tm5c (R) | Glu | 75 | 75.0 | 1.9% | 87.2% |
| 9 | MeTu1 (R) | ACh | 59 | 59.0 | 1.5% | 88.7% |
| 10 | MeVPMe11 (L) | Glu | 52 | 52.0 | 1.3% | 90.0% |
| 11 | Cm14 (R) | GABA | 33 | 33.0 | 0.8% | 90.8% |
| 12 | Cm18 (R) | Glu | 32 | 32.0 | 0.8% | 91.6% |
| 13 | Dm2 (R) | ACh | 23 | 23.0 | 0.6% | 92.2% |
| 14 | Cm30 (R) | GABA | 19 | 19.0 | 0.5% | 92.7% |
| 15 | MeVP14 (R) | ACh | 19 | 19.0 | 0.5% | 93.1% |
| 16 | Cm21 (R) | GABA | 18 | 18.0 | 0.4% | 93.6% |
| 17 | aMe17b (R) | GABA | 17 | 17.0 | 0.4% | 94.0% |
| 18 | Cm3 (R) | GABA | 17 | 17.0 | 0.4% | 94.4% |
| 19 | Cm9 (R) | Glu | 15 | 15.0 | 0.4% | 94.8% |
| 20 | aMe9 (R) | ACh | 13 | 13.0 | 0.3% | 95.1% |
| 21 | Cm24 (R) | Glu | 12 | 12.0 | 0.3% | 95.4% |
| 22 | MeVP15 (R) | ACh | 11 | 11.0 | 0.3% | 95.7% |
| 23 | TmY17 (R) | ACh | 10 | 10.0 | 0.2% | 96.0% |
| 24 | MeVP43 (R) | ACh | 9 | 9.0 | 0.2% | 96.2% |
| 25 | MeLo3b (R) | ACh | 8 | 8.0 | 0.2% | 96.4% |
| 26 | MeVP21 (R) | ACh | 8 | 8.0 | 0.2% | 96.6% |
| 27 | aMe5 (R) | ACh | 7 | 7.0 | 0.2% | 96.8% |
| 28 | Tm39 (R) | ACh | 7 | 7.0 | 0.2% | 96.9% |
| 29 | aMe12 (R) | ACh | 6 | 6.0 | 0.1% | 97.1% |
| 30 | Cm31a (R) | GABA | 5 | 5.0 | 0.1% | 97.2% |
| 31 | Cm6 (R) | GABA | 5 | 5.0 | 0.1% | 97.3% |
| 32 | LT58 (R) | Glu | 5 | 5.0 | 0.1% | 97.5% |
| 33 | MeVP9 (R) | ACh | 5 | 5.0 | 0.1% | 97.6% |
| 34 | aMe10 (L) | ACh | 4 | 4.0 | 0.1% | 97.7% |
| 35 | aMe22 (R) | Glu | 4 | 4.0 | 0.1% | 97.8% |
| 36 | ME_unclear (R) | ACh | 4 | 4.0 | 0.1% | 97.9% |
| 37 | MeLo6 (R) | ACh | 4 | 4.0 | 0.1% | 98.0% |
| 38 | MeVP8 (R) | ACh | 4 | 4.0 | 0.1% | 98.1% |
| 39 | Tm37 (R) | Glu | 4 | 4.0 | 0.1% | 98.2% |
| 40 | aMe17a (R) | Glu | 3 | 3.0 | 0.1% | 98.3% |
| 41 | Cm35 (R) | GABA | 3 | 3.0 | 0.1% | 98.3% |
| 42 | MeTu2b (R) | unclear | 3 | 3.0 | 0.1% | 98.4% |
| 43 | MeVP40 (R) | unclear | 3 | 3.0 | 0.1% | 98.5% |
| 44 | MeVP41 (R) | ACh | 3 | 3.0 | 0.1% | 98.6% |
| 45 | MeVP49 (R) | unclear | 3 | 3.0 | 0.1% | 98.6% |
| 46 | MeVP7 (R) | ACh | 3 | 3.0 | 0.1% | 98.7% |
| 47 | OA-AL2i4 (R) | OA | 3 | 3.0 | 0.1% | 98.8% |
| 48 | aMe17e (R) | Glu | 2 | 2.0 | 0.0% | 98.8% |
| 49 | aMe30 (R) | Glu | 2 | 2.0 | 0.0% | 98.9% |
| 50 | Cm10 (R) | GABA | 2 | 2.0 | 0.0% | 98.9% |
| 51 | Cm16 (R) | Glu | 2 | 2.0 | 0.0% | 99.0% |
| 52 | Cm22 (R) | GABA | 2 | 2.0 | 0.0% | 99.0% |
| 53 | Cm4 (R) | Glu | 2 | 2.0 | 0.0% | 99.1% |
| 54 | Lat3 (R) | unclear | 2 | 2.0 | 0.0% | 99.1% |
| 55 | MeLo5 (R) | ACh | 2 | 2.0 | 0.0% | 99.2% |
| 56 | MeTu2a (R) | ACh | 2 | 2.0 | 0.0% | 99.2% |
| 57 | MeVP1 (R) | ACh | 2 | 2.0 | 0.0% | 99.3% |
| 58 | MeVP42 (R) | ACh | 2 | 2.0 | 0.0% | 99.3% |
| 59 | TmY13 (R) | ACh | 2 | 2.0 | 0.0% | 99.4% |
| 60 | aMe10 (R) | ACh | 1 | 1.0 | 0.0% | 99.4% |
| 61 | aMe3 (R) | Glu | 1 | 1.0 | 0.0% | 99.4% |
| 62 | Cm-DRA (R) | ACh | 1 | 1.0 | 0.0% | 99.5% |
| 63 | Cm1 (R) | ACh | 1 | 1.0 | 0.0% | 99.5% |
| 64 | Cm17 (R) | GABA | 1 | 1.0 | 0.0% | 99.5% |
| 65 | Cm2 (R) | ACh | 1 | 1.0 | 0.0% | 99.5% |
| 66 | Cm23 (R) | Glu | 1 | 1.0 | 0.0% | 99.6% |
| 67 | Cm25 (R) | Glu | 1 | 1.0 | 0.0% | 99.6% |
| 68 | Cm28 (R) | unclear | 1 | 1.0 | 0.0% | 99.6% |
| 69 | Cm31b (R) | GABA | 1 | 1.0 | 0.0% | 99.6% |
| 70 | Cm5 (R) | GABA | 1 | 1.0 | 0.0% | 99.7% |
| 71 | Cm7 (R) | Glu | 1 | 1.0 | 0.0% | 99.7% |
| 72 | Cm8 (R) | GABA | 1 | 1.0 | 0.0% | 99.7% |
| 73 | MeLo7 (R) | ACh | 1 | 1.0 | 0.0% | 99.7% |
| 74 | MeVP6 (R) | Glu | 1 | 1.0 | 0.0% | 99.8% |
| 75 | MeVPLo2 (R) | ACh | 1 | 1.0 | 0.0% | 99.8% |
| 76 | MeVPMe12 (R) | ACh | 1 | 1.0 | 0.0% | 99.8% |
| 77 | MeVPMe4 (L) | Glu | 1 | 1.0 | 0.0% | 99.8% |
| 78 | MeVPMe9 (L) | Glu | 1 | 1.0 | 0.0% | 99.9% |
| 79 | Mi16 (R) | GABA | 1 | 1.0 | 0.0% | 99.9% |
| 80 | Mi19 (R) | 5HT | 1 | 1.0 | 0.0% | 99.9% |
| 81 | T2 (R) | ACh | 1 | 1.0 | 0.0% | 99.9% |
| 82 | Tm16 (R) | ACh | 1 | 1.0 | 0.0% | 100.0% |
| 83 | Tm26 (R) | ACh | 1 | 1.0 | 0.0% | 100.0% |
| 84 | Tm29 (R) | Glu | 1 | 1.0 | 0.0% | 100.0% |
| instance | NT | total connections | connections /#MeVPMe11 (R) | % | % cumu. | |
|---|---|---|---|---|---|---|
| 0 | aMe12 (R) | ACh | 2 | 2.0 | 13.3% | 13.3% |
| 1 | aMe30 (R) | Glu | 1 | 1.0 | 6.7% | 20.0% |
| 2 | aMe4 (R) | ACh | 1 | 1.0 | 6.7% | 26.7% |
| 3 | Cm10 (R) | GABA | 1 | 1.0 | 6.7% | 33.3% |
| 4 | Cm29 (R) | GABA | 1 | 1.0 | 6.7% | 40.0% |
| 5 | Cm32 (R) | GABA | 1 | 1.0 | 6.7% | 46.7% |
| 6 | MeVP2 (R) | ACh | 1 | 1.0 | 6.7% | 53.3% |
| 7 | MeVP21 (R) | ACh | 1 | 1.0 | 6.7% | 60.0% |
| 8 | MeVP47 (R) | unclear | 1 | 1.0 | 6.7% | 66.7% |
| 9 | MeVP57 (R) | unclear | 1 | 1.0 | 6.7% | 73.3% |
| 10 | MeVPMe13 (L) | ACh | 1 | 1.0 | 6.7% | 80.0% |
| 11 | MeVPMe13 (R) | ACh | 1 | 1.0 | 6.7% | 86.7% |
| 12 | Mi16 (R) | GABA | 1 | 1.0 | 6.7% | 93.3% |
| 13 | OA-AL2i4 (R) | OA | 1 | 1.0 | 6.7% | 100.0% |